Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hyperprolactinemia × 1 year × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 56 Prostatic Neoplasms 23 Neoplasms 21 Multiple Myeloma 18 Carcinoma, Hepatocellular 15 Stomach Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 11 Papillomavirus Infections 9 Lung Neoplasms 9 Pain, Postoperative 8 Waldenstrom Macroglobulinemia 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Melanoma 7 Polycystic Ovary Syndrome 6 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Lymphoma, Non-Hodgkin 6 Leukemia, Myeloid, Acute 6 Leiomyoma 6 Brain Neoplasms 6 Venous Thromboembolism 5 Smoking Cessation 5 Sarcoma 5 Recurrence 5 Lymphoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Hematologic Neoplasms 5 Glioma 5

Interventions

Dopamine Agonists 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡